NorthStar Medical Radioisotopes, LLC
Jean-Noel David is an accomplished professional with extensive experience in executive leadership roles across the pharmaceutical and consulting industries. Currently serving as Vice President of Operations at NorthStar Medical Radioisotopes, LLC since April 2023, David previously held the position of Vice President of Cell & Gene Therapy at Catalent Pharma Solutions from July 2021 to July 2022. David's career also includes roles such as Managing Director at SEQENS CDMO, Vice President of Business Transformation at Patheon, and Strategy Consultant at IBM Global Business Services, among others. Academic credentials include an MBA in Strategy and Finance from Emory University, a Master of Science in Mechanical Engineering from ENSTA Paris, and a Bachelor of Science in Mechanical Engineering from Pierre and Marie Curie University.
This person is not in the org chart
This person is not in any offices
NorthStar Medical Radioisotopes, LLC
NorthStar Medical Radioisotopes LLC (northstarnm.com) was founded in 2006 to address the needs of the nuclear medicine market in the United States. A wholly owned subsidiary of NorthStar Medical Technologies LLC, the company is committed to resolving industry-wide supply challenges that have caused shortages of vital medical isotopes, negativelyimpacting patient care and stalling clinical research. Its patented technologies include innovative non-uranium based molybdenum-99 production methods, a novel separation chemistry system and tools for the nuclear medicine market.